Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. uri icon

Overview

publication date

  • May 24, 2012

Research

keywords

  • Antibodies, Anti-Idiotypic
  • Psoriasis
  • Receptors, Interleukin-17

Identity

Scopus Document Identifier

  • 84866391313

Digital Object Identifier (DOI)

  • 10.1038/jid.2012.163

PubMed ID

  • 22622425

Additional Document Info

volume

  • 132

issue

  • 10